JP2024526060A5 - - Google Patents
Info
- Publication number
- JP2024526060A5 JP2024526060A5 JP2023575534A JP2023575534A JP2024526060A5 JP 2024526060 A5 JP2024526060 A5 JP 2024526060A5 JP 2023575534 A JP2023575534 A JP 2023575534A JP 2023575534 A JP2023575534 A JP 2023575534A JP 2024526060 A5 JP2024526060 A5 JP 2024526060A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- hvr
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208238P | 2021-06-08 | 2021-06-08 | |
| US63/208,238 | 2021-06-08 | ||
| US202163209360P | 2021-06-10 | 2021-06-10 | |
| US63/209,360 | 2021-06-10 | ||
| US202163225916P | 2021-07-26 | 2021-07-26 | |
| US63/225,916 | 2021-07-26 | ||
| US202163277069P | 2021-11-08 | 2021-11-08 | |
| US63/277,069 | 2021-11-08 | ||
| US202263304522P | 2022-01-28 | 2022-01-28 | |
| US63/304,522 | 2022-01-28 | ||
| US202263311379P | 2022-02-17 | 2022-02-17 | |
| US63/311,379 | 2022-02-17 | ||
| PCT/US2022/072827 WO2022261648A2 (en) | 2021-06-08 | 2022-06-08 | Methods of use of anti-sortilin antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526060A JP2024526060A (ja) | 2024-07-17 |
| JP2024526060A5 true JP2024526060A5 (cg-RX-API-DMAC7.html) | 2025-06-16 |
Family
ID=84426402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575534A Withdrawn JP2024526060A (ja) | 2021-06-08 | 2022-06-08 | 抗ソルチリン抗体の使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240132597A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4351728A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526060A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023025188A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3220428A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022261648A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3618928T (lt) | 2018-07-13 | 2023-04-11 | Alector Llc | Anti-sortilino antikūnai ir jų panaudojimo būdai |
| WO2025031098A1 (zh) * | 2023-08-09 | 2025-02-13 | 瑞诺元(苏州)生物科技有限公司 | 一种分拣蛋白1特异性的纳米抗体、含有其的重组aav及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119679944A (zh) * | 2018-01-25 | 2025-03-25 | 渤健马萨诸塞州股份有限公司 | 治疗脊髓性肌萎缩症的方法 |
| EP3983441A1 (en) * | 2019-06-11 | 2022-04-20 | Alector LLC | Anti-sortilin antibodies for use in therapy |
-
2022
- 2022-06-08 CA CA3220428A patent/CA3220428A1/en active Pending
- 2022-06-08 EP EP22821249.4A patent/EP4351728A4/en not_active Withdrawn
- 2022-06-08 JP JP2023575534A patent/JP2024526060A/ja not_active Withdrawn
- 2022-06-08 BR BR112023025188A patent/BR112023025188A2/pt unknown
- 2022-06-08 WO PCT/US2022/072827 patent/WO2022261648A2/en not_active Ceased
-
2023
- 2023-12-07 US US18/532,382 patent/US20240132597A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10875909B2 (en) | Humanized antibodies that recognize alpha-synuclein | |
| JP7357609B2 (ja) | 抗トランスサイレチン抗体 | |
| JP6511396B2 (ja) | アルファ−シヌクレイン認識抗体 | |
| JP2023520516A5 (cg-RX-API-DMAC7.html) | ||
| JP2024526060A5 (cg-RX-API-DMAC7.html) | ||
| KR20230145400A (ko) | 항-아밀로이드 베타 항체 및 그의 용도 | |
| JP6560808B2 (ja) | 抗（＋）メタンフェタミンモノクローナル抗体 | |
| JP2022512937A5 (cg-RX-API-DMAC7.html) | ||
| TW202231661A (zh) | 安全投予抗ｔａｕ抗體之方法 | |
| JP2024540294A (ja) | アルツハイマー病を治療するための方法 | |
| EP4448005A1 (en) | Methods of using an anti-amyloid beta protofibril antibody and anti-tau antibody | |
| JP2022514381A5 (cg-RX-API-DMAC7.html) | ||
| TW202233666A (zh) | 減少人類對象中之ｔａｕ的方法 | |
| AU2024283314A1 (en) | Therapeutic use of bispecific anti-abeta/tfr antibodies | |
| CN113924099A (zh) | 针对免疫球蛋白轻链的单克隆抗体与抗体产生细胞和其他免疫细胞上的cd38细胞膜分子的组合治疗al淀粉样变性 | |
| JP2023542521A5 (cg-RX-API-DMAC7.html) | ||
| JP2023075242A (ja) | 再発型の多発性硬化症を治療するための方法 | |
| CN118829445A (zh) | 用于治疗阿尔茨海默病的方法 | |
| CN116829582A (zh) | 安全施用抗Tau抗体的方法 | |
| WO2026035942A1 (en) | Combinatorial therapy for alzheimer's disease | |
| WO2024069236A1 (en) | Methods for treating inactive or chronic thyroid eye disease | |
| CN118450905A (zh) | 使用抗淀粉样蛋白β初原纤维抗体和抗τ蛋白抗体的方法 | |
| WO2024112561A1 (en) | Methods for the treatment of myasthenia gravis | |
| HK40100364A (zh) | 减少人类受试者中的tau的方法 |